ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $772 | +243.1% | 605,700 | -12.2% | 0.00% | – |
| Q2 2023 | $225 | -8.2% | 689,713 | +21.1% | 0.00% | – |
| Q1 2023 | $245 | -44.9% | 569,700 | -32.2% | 0.00% | -100.0% |
| Q4 2022 | $445 | -99.9% | 840,500 | -24.3% | 0.00% | 0.0% |
| Q3 2022 | $813,000 | -3.2% | 1,110,035 | +50.7% | 0.00% | 0.0% |
| Q2 2022 | $840,000 | +24.8% | 736,600 | +124.3% | 0.00% | 0.0% |
| Q1 2022 | $673,000 | -39.9% | 328,400 | -15.4% | 0.00% | 0.0% |
| Q4 2021 | $1,119,000 | -26.1% | 388,385 | +8.8% | 0.00% | -50.0% |
| Q3 2021 | $1,514,000 | +218.7% | 356,982 | +147.9% | 0.00% | +100.0% |
| Q4 2020 | $475,000 | +666.1% | 144,000 | +674.2% | 0.00% | – |
| Q3 2020 | $62,000 | -88.7% | 18,600 | -89.9% | 0.00% | -100.0% |
| Q4 2018 | $547,000 | – | 184,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |